SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-080104
Filing Date
2022-03-21
Accepted
2022-03-21 08:38:04
Documents
6
Effectiveness Date
2022-03-21

Document Format Files

Seq Description Document Type Size
1 S-8 d313476ds8.htm S-8 29417
2 EX-5.1 d313476dex51.htm EX-5.1 10029
3 EX-23.1 d313476dex231.htm EX-23.1 1403
4 EX-FILING FEES d313476dexfilingfees.htm EX-FILING FEES 14600
5 GRAPHIC g313476ex51.jpg GRAPHIC 11409
6 GRAPHIC g313476g0308053520844.jpg GRAPHIC 5426
  Complete submission text file 0001193125-22-080104.txt   79879
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263729 | Film No.: 22754296
SIC: 2834 Pharmaceutical Preparations